Literature DB >> 26878305

Charge Type, Charge Spacing, and Hydrophobicity of Arginine-Rich Cell-Penetrating Peptides Dictate Gene Transfection.

Nabil A Alhakamy1, Prajnaparamita Dhar1,2, Cory J Berkland1,2.   

Abstract

Noncovalent complexation of plasmid DNA (pDNA) with cell-penetrating peptides (CPPs) forms relatively large complexes with poor gene expression. Yet, condensing these CPP-pDNA complexes via addition of calcium chloride produces small and stable nanoparticles with high levels of gene expression. This simple formulation offered high transfection efficiency and negligible cytotoxicity in HEK-293 (a virus-immortalized kidney cell) and A549 (a human lung cancer cell line). Small changes in CPP charge type, charge spacing, and hydrophobicity were studied by using five arginine-rich CPPs: the well-known hydrophilic polyarginine R9 peptide, a hydrophilic RH9 peptide, and three amphiphilic peptides (RA9, RL9, and RW9) with charge distributions that favor membrane penetration. R9 and RW9 nanoparticles were significantly more effective than the other CPPs under most formulation conditions. However, these CPPs exhibit large differences in membrane penetration potential. Maximum transfection resulted from an appropriate balance of complexing with pDNA, releasing DNA, and membrane penetration potential.

Entities:  

Keywords:  amphiphilic; arginine-rich; calcium chloride; cell-penetrating peptides; gene delivery; hydrophilic; nonviral; plasmid DNA; polyarginine; transfection

Mesh:

Substances:

Year:  2016        PMID: 26878305     DOI: 10.1021/acs.molpharmaceut.5b00871

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  8 in total

1.  Increased Hydrophobic Block Length of PTDMs Promotes Protein Internalization.

Authors:  Coralie M Backlund; Federica Sgolastra; Ronja Otter; Lisa Minter; Toshihide Takeuchi; Shiroh Futaki; Gregory N Tew
Journal:  Polym Chem       Date:  2016-11-14       Impact factor: 5.582

2.  Cartilage penetrating cationic peptide carriers for applications in drug delivery to avascular negatively charged tissues.

Authors:  Armin Vedadghavami; Erica K Wagner; Shikhar Mehta; Tengfei He; Chenzhen Zhang; Ambika G Bajpayee
Journal:  Acta Biomater       Date:  2018-12-06       Impact factor: 8.947

3.  Improving Cell Penetration of Gold Nanorods by Using an Amphipathic Arginine Rich Peptide.

Authors:  Ana L Riveros; Cynthia Eggeling; Sebastián Riquelme; Carolina Adura; Carmen López-Iglesias; Fanny Guzmán; Eyleen Araya; Mario Almada; Josué Juárez; Miguel A Valdez; Ignacio A Fuentevilla; Olga López; Marcelo J Kogan
Journal:  Int J Nanomedicine       Date:  2020-03-17

4.  Surface density of polyarginine influence the size, zeta potential, cellular uptake and tissue distribution of the nanostructured lipid carrier.

Authors:  Mingshuang Sun; Zhihong Zhu; Huixin Wang; Cuiyan Han; Dandan Liu; Lei Tian; Xinggang Yang; Weisan Pan
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  TRAIL mutant membrane penetrating peptide alike-MuR6-TR enhances the antitumor effects of TRAIL in pancreatic carcinoma both in vitro and in vivo.

Authors:  Lei Sun; Chen Chen; Aijing Zhu; Ying Huang; Hong Zhu; Cheng Yi
Journal:  Int J Mol Med       Date:  2017-04-26       Impact factor: 4.101

Review 6.  Membrane Internalization Mechanisms and Design Strategies of Arginine-Rich Cell-Penetrating Peptides.

Authors:  Minglu Hao; Lei Zhang; Pu Chen
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

7.  Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment.

Authors:  Wei Bin Fang; Min Yao; Gage Brummer; Diana Acevedo; Nabil Alhakamy; Cory Berkland; Nikki Cheng
Journal:  Oncotarget       Date:  2016-08-02

Review 8.  Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery.

Authors:  Prisca Boisguérin; Karidia Konate; Emilie Josse; Eric Vivès; Sébastien Deshayes
Journal:  Biomedicines       Date:  2021-05-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.